1. Home
  2. LEGN vs KT Comparison

LEGN vs KT Comparison

Compare LEGN & KT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • KT
  • Stock Information
  • Founded
  • LEGN 2014
  • KT 1981
  • Country
  • LEGN United States
  • KT South Korea
  • Employees
  • LEGN N/A
  • KT N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • KT Telecommunications Equipment
  • Sector
  • LEGN Health Care
  • KT Telecommunications
  • Exchange
  • LEGN Nasdaq
  • KT Nasdaq
  • Market Cap
  • LEGN 7.8B
  • KT 9.0B
  • IPO Year
  • LEGN 2020
  • KT 1999
  • Fundamental
  • Price
  • LEGN $34.68
  • KT $16.34
  • Analyst Decision
  • LEGN Strong Buy
  • KT
  • Analyst Count
  • LEGN 13
  • KT 0
  • Target Price
  • LEGN $81.54
  • KT N/A
  • AVG Volume (30 Days)
  • LEGN 1.5M
  • KT 3.2M
  • Earning Date
  • LEGN 11-12-2024
  • KT 02-10-2025
  • Dividend Yield
  • LEGN N/A
  • KT 4.46%
  • EPS Growth
  • LEGN N/A
  • KT 0.16
  • EPS
  • LEGN N/A
  • KT 3.60
  • Revenue
  • LEGN $520,183,000.00
  • KT $20,141,581,365.00
  • Revenue This Year
  • LEGN $120.77
  • KT $2.80
  • Revenue Next Year
  • LEGN $68.54
  • KT $2.82
  • P/E Ratio
  • LEGN N/A
  • KT $8.84
  • Revenue Growth
  • LEGN 122.96
  • KT 0.74
  • 52 Week Low
  • LEGN $32.66
  • KT $12.10
  • 52 Week High
  • LEGN $70.13
  • KT $18.45
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 32.71
  • KT 49.82
  • Support Level
  • LEGN $40.97
  • KT $15.64
  • Resistance Level
  • LEGN $43.96
  • KT $16.57
  • Average True Range (ATR)
  • LEGN 2.03
  • KT 0.36
  • MACD
  • LEGN -0.72
  • KT -0.13
  • Stochastic Oscillator
  • LEGN 16.97
  • KT 24.73

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About KT KT Corporation

KT is South Korea's largest fixed-line telecom operator, with around 11.7 million fixed-line broadband customers and 9.4 million IPTV customers, and is the second-largest wireless operator with 25 million subscribers. Additionally, it has a number of nontelecom businesses, including real estate, payment processing, artificial intelligence, and IDC/cloud services, many of which are the focus of its growth strategy. The company was formed from the previously government-owned, monopoly telecom business and was listed in 1998. After selling its mobile business in 1994 (forming its mobile competitor, SK Telecom) KT created its own mobile operator in 1997.

Share on Social Networks: